Chronic pain clinical trials in Kitchener, Ontario
Part of chronic pain trials in Ontario.
5
Trials
0
Recruiting or not yet
5
Trial sites
Trials with a site in Kitchener
5 trials, recruiting first
| Phase | ||||
|---|---|---|---|---|
| Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome NCT02858453 | Unknown status | Phase 3 | Aquinox Pharmaceuticals (Canada) Inc. | 2016-07 |
| An Evaluation of the Effect of Community-based Pharmacist Intervention on Patients With Chronic Pain NCT03087331 | Completed | Not applicable | University of Waterloo | 2016-02 |
| A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain NCT01060254 | Terminated | Phase 2 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-04-06 |
| An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis NCT00826514 | Completed | Phase 2 | Pfizer | 2009-03-25 |
| An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain NCT00487435 | Completed | Phase 3 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-06 |
Facilities listed in the registry
- Urology Associates / Urologic Medical Research (1 trial site)
- Site 1003 (1 trial site)
- The PharmaShoppe (1 trial site)
Facility names are as entered by study registrants. This is not a clinic directory.
Map
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.